2020 Patient Education Events

Congratulations to our 2020 Patient Impact Awardees:

spark-stanford

2020 Janet Davison Rowley Patient Impact Research Award

spark-stanford

2020 Golan Christie Taglia Patient Impact Philanthropy Award

spark-stanford

2020 Patient Impact Industry Award

Thank you to all who joined us this year for our virtual Fall 2020 patient education events to help honor these amazing organizations.

Repurposing for Pediatric Patients: Best Practices and Lessons Learned

November 2 at 1pm ET

A conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.  New FDA approved treatments are often developed for adults with specific diseases, while the needs of the pediatric patient is often underserved or overlooked for a variety of reasons.  Speakers will provide the perspectives of industry, research, not-for-profit and the patient voice.

Moderator: Mary B. Leonard, MD, MSCE, Adalyn Jay Physician in Chief, Lucile Packard Children’s Hospital Stanford, Arline and Pete Harman Professor and Chair, Department of Pediatrics; and Director, Stanford Maternal and Child Health Research Institute, Stanford School of Medicine

Speakers: 

Ben McGraw, PharmD, Executive Chairman, Auration Biotech

Teresa Purzner, MD, SIGF and BioX fellow, SPARK scholar, Stanford University; Chief Neurosurgery Resident, University of Toronto

Dr. Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases, DNDi

 

How Patients Impact the 505(b)(2) Regulatory Process

October 19 at 5pm ET

A conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.  Speakers will provide the perspectives of industry, research, not-for-profit and the patient voice.

Moderator: Andrea Furia-Helms, MPH, Director, Patient Affairs Staff, US FDA

Speakers:

Tamy Kim, PharmD, Associate Director, Oncology Center of Excellence, US FDA

Daniel Lewi, Founder of CATS Foundation

Ken Phelps, President and Founder of Camargo Pharmaceutical Services

Register for just one event, or join us for both events at a discounted rate!

Registration now closed.

After each of these panel sessions, Cures Within Reach presented SPARK at StanfordDrugs for Neglected Diseases initiative and Camargo Pharmaceutical Services with their 2020 Patient Impact Awards, recognizing each organization’s outstanding achievements in creating impact for patients by repurposing existing science and medicine.

During these patient-focused events, Cures Within Reach celebrated:

  • Stanford SPARK’s interest in and support of the translational development of repurposing opportunities for both commercial and philanthropic treatments for patients with unmet medical needs, in a range of diseases via drugs, devices and other technologies.
  • DNDi’s efforts to develop eight new treatments from existing molecules and recombining drugs to bring better treatments to patients with malaria, Chagas disease, sleeping sickness, leishmaniasis, and pediatric HIV.
  • Camargo’s dedication to supporting the regulatory approval and development of proven therapies that enhance patient outcomes through the 505(b)(2) pathway and similar pathways worldwide. As a trailblazer, Camargo and its founders were involved with the first private sector drug approval using the 505(b)(2) pathway – and since 2003 have improved countless patient lives by helping industry advance these therapies through regulatory approval.

Read the entire press release HERE.  To join us in celebrating these 2020 Awardees as a Planning Committee member, through sponsorship or in other ways, please email info@cureswithinreach.org.

Background: Awards are given to industry leaders, scientists, philanthropists and organizations driving improvements in clinical care through repurposing at several events throughout 2020, part of Cures Within Reach’s largest annual fundraiser.  These events celebrate our collective commitment to patient impact through repurposing. In 2020, Cures Within Reach will honor these three recipients in locations that best celebrate the honorees in their own communities, with the people who best can help us honor them.

Thanks to our Patient Education supporters as well as from our Repurposing Community Industry Members

fujifilm
Recordati Rare Diseases supports repurposing research
Takeda Pharmaceuticals supports repurposing research
TerSera Therapeutics supports repurposing research
Brand Institute supports repurposing research
Golan Christie Taglia supports repurposing research
Healx supports repurposing research

Honoring leadership in medical repurposing

To learn about sponsorship opportunities, email GHRA@cureswithinreach.org

 Questions? Contact Clare Thibodeaux, PhD, Director of Scientific Affairs: clare@cureswithinreach.org or 847-745-1250